1. Gilead may be looking to buy oncology startup Forty-Seven —FDA announces that COVID-19 has caused its first US drug shortage — Passage Bio raises upsized $216M IPO — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Nuvasive deformity Correction Offering

Discussion in 'NuVasive' started by peter cairns, Jun 21, 2019 at 12:36 AM.

  1. peter cairns

    peter cairns new user

    Jun 21, 2019
    Likes Received:
    Interested in those who have come up against Nuvasive deformity correction/scoliosis offering. Former employees with insights would be of great help. From what I understand, what they have is quite good. Very hard to find information on it.